Performance stock units issued and outstanding (unvested) under 2020 Equity Incentive Plan (in shares)
Common Stock, Capital Shares Reserved for Future Issuance, Effect Of Performance Stock Units Available For Future Grant
Common Stock, Capital Shares Reserved for Future Issuance, Effect Of Performance Stock Units Available For Future Grant
Agent fee percentage
Sale of Stock, Sales Agent Fee, Percentage Of Gross Proceeds
Sale of Stock, Sales Agent Fee, Percentage Of Gross Proceeds
Proceeds from issuance of pre-funded warrants, net of paid issuance costs
Proceeds from Issuance of Warrants
Adjustments to reconcile net loss to net cash used in operating activities:
Adjustments to Reconcile Net Income (Loss) to Cash Provided by (Used in) Operating Activities [Abstract]
Statistical Measurement [Domain]
Statistical Measurement [Domain]
RELATED PARTY TRANSACTIONS
Related Party Transactions Disclosure [Text Block]
Unrealized losses
Debt Securities, Available-for-Sale, Accumulated Gross Unrealized Loss, before Tax
Prepaid expenses
Increase (Decrease) in Prepaid Expense
Schedule of Components of Lease Cost
Lease, Cost [Table Text Block]
Cover [Abstract]
Net increase (decrease) in cash, cash equivalents and restricted cash
Cash, Cash Equivalents, Restricted Cash, and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect
Schedule of Future Contractual Lease Payments
Lessee, Operating Lease, Liability, to be Paid, Maturity [Table Text Block]
Trading Symbol
Trading Symbol
Segment Reporting Information [Line Items]
Segment Reporting Information [Line Items]
Maximum milestone payments
Collaborative Arrangement, Maximum Milestone Payment
Collaborative Arrangement, Maximum Milestone Payment
All Trading Arrangements
All Trading Arrangements [Member]
Compensation Actually Paid vs. Net Income
Compensation Actually Paid vs. Net Income [Text Block]
Non-NEOs
Non-NEOs [Member]
Proceeds from warrant cancellation payment
Proceeds From Cancellation Of Warrants
Proceeds From Cancellation Of Warrants
Schedule of Computation of Basic and Diluted Net Loss Per Share
Schedule of Earnings Per Share, Basic and Diluted [Table Text Block]
Tenant improvement allowance
Lessee, Tenant Improvement Allowance
Lessee, Tenant Improvement Allowance
Rule 10b5-1 Arrangement Adopted
Rule 10b5-1 Arrangement Adopted [Flag]
Awards Close in Time to MNPI Disclosures
Awards Close in Time to MNPI Disclosures [Table]
Pay vs Performance Disclosure [Line Items]
Peer Group Total Shareholder Return Amount
Peer Group Total Shareholder Return Amount
Preferred stock purchased
Payments to Acquire Equity Securities, FV-NI
Accounts receivable, net
Increase (Decrease) in Accounts Receivable
Unrealized loss on equity investments
Equity Securities, FV-NI, Gain (Loss)
Net Loss per Share
Earnings Per Share, Policy [Policy Text Block]
Inventory
Inventory, Policy [Policy Text Block]
Non-Rule 10b5-1 Arrangement Adopted
Non-Rule 10b5-1 Arrangement Adopted [Flag]
FAIR VALUE MEASUREMENTS
Fair Value Disclosures [Text Block]
Proceeds from exercise of stock options
Proceeds from Stock Options Exercised
Award Timing Disclosures [Line Items]
2016 Plan
Equity Incentive Plan 2016 [Member]
Equity Incentive Plan 2016
Other Performance Measure, Amount
Other Performance Measure, Amount
2028
Finite-Lived Intangible Asset, Expected Amortization, Year Three
Common stock, outstanding (in shares)
Beginning balance (in shares)
Ending balance (in shares)
Common Stock, Shares, Outstanding
Operating lease expense
Operating Lease, Cost
Other receivables
Other Receivables, Net, Current
Proceeds from maturities of marketable securities
Proceeds from Sale and Maturity of Marketable Securities
Operating lease liability, noncurrent
Operating Lease, Liability, Noncurrent
Collaborative Arrangement and Arrangement Other than Collaborative [Line Items]
Collaborative Arrangement and Arrangement Other than Collaborative [Line Items]
Plan Name [Domain]
Plan Name [Domain]
Original issue price (usd per share)
Sale of Stock, Price Per Share
Other assets
Other Assets, Noncurrent
Entity Tax Identification Number
Entity Tax Identification Number
Antidilutive Securities, Name [Domain]
Antidilutive Securities, Name [Domain]
Money market funds
Money Market Funds [Member]
Selling, general and administrative
Selling, General and Administrative Expenses [Member]
Net cash used in operating activities
Net Cash Provided by (Used in) Operating Activities
Stock issued, net proceeds
Sale of Stock, Consideration Received on Transaction
Cash Flows From Operating Activities:
Net Cash Provided by (Used in) Operating Activities [Abstract]
U.S. Treasury securities
US Treasury Securities [Member]
Raw materials
Inventory, Raw Materials, Noncurrent, Net of Reserves
Inventory, Raw Materials, Noncurrent, Net of Reserves
Plan Name [Axis]
Plan Name [Axis]
Prepaid expenses
Prepaid Expense, Current
Equity Components [Axis]
Equity Components [Axis]
Share-based Payment Arrangement, Expensed and Capitalized, Amount [Line Items]
Share-Based Payment Arrangement, Expensed and Capitalized, Amount [Line Items]
Award Timing Method
Award Timing Method [Text Block]
Office equipment
Office Equipment [Member]
Non-cash lease expense
Operating Lease, Noncash Expense
Operating Lease, Noncash Expense
Research and Development Costs
Research and Development Expense, Policy [Policy Text Block]
Trading Arrangements, by Individual
Trading Arrangements, by Individual [Table]
Corporate debt securities
Debt Securities, Available-for-Sale
Accounts Receivable, Net
Accounts Receivable [Policy Text Block]
Entity Common Stock, Shares Outstanding
Entity Common Stock, Shares Outstanding
Insider Trading Policies and Procedures [Line Items]
Use of Estimates
Use of Estimates, Policy [Policy Text Block]
Total operating expenses
Costs and Expenses
Adjustment to Compensation, Amount
Adjustment to Compensation Amount
Outstanding
Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Outstanding, Intrinsic Value
Compensation Amount
Outstanding Recovery Compensation Amount
Unrealized gains
Cash And Cash Equivalents, Accumulated Unrealized Gains, Before Tax
Cash And Cash Equivalents, Accumulated Unrealized Gains, Before Tax
Aggregate Change in Present Value of Accumulated Benefit for All Pension Plans Reported in Summary Compensation Table
Aggregate Change in Present Value of Accumulated Benefit for All Pension Plans Reported in Summary Compensation Table [Member]
Entity Smaller Reporting Company
Entity Small Business
Company Selected Measure Amount
Company Selected Measure Amount
Tabular List, Table
Tabular List [Table Text Block]
Level 3
Fair Value, Inputs, Level 3 [Member]
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Share-Based Compensation Arrangement by Share-Based Payment Award [Line Items]
Contractual milestone payment net sales
Collaborative Arrangement, Rights And Obligations, Contractual Milestone, Net Sales
Collaborative Arrangement, Rights And Obligations, Contractual Milestone, Net Sales
Aggregate Grant Date Fair Value of Equity Award Amounts Reported in Summary Compensation Table
Aggregate Grant Date Fair Value of Equity Award Amounts Reported in Summary Compensation Table [Member]
Pre-funded warrants to purchase common stock (in shares)
Class of Warrant or Right, Number of Securities Called by Warrants or Rights
Lessee, Lease, Description [Line Items]
Lessee, Lease, Description [Line Items]
Debt Securities, Available-for-Sale [Line Items]
Debt Securities, Available-for-Sale [Line Items]
Antidilutive securities excluded from computation of net income (loss) per share (in shares)
Antidilutive Securities Excluded from Computation of Earnings Per Share, Amount
Base rent expense
Operating Lease, Expense
Cost of Sales
Cost of Goods and Service [Policy Text Block]
Cash, cash equivalents and restricted cash at beginning of period
Cash, cash equivalents and restricted cash at end of period
Cash, Cash Equivalents, Restricted Cash, and Restricted Cash Equivalents
Net amortization/accretion of marketable securities
Accretion (Amortization) of Discounts and Premiums, Investments
Pharmakon Credit Facility, Tranche One
Pharmakon Credit Facility, Tranche One [Member]
Pharmakon Credit Facility, Tranche One
Current assets:
Assets, Current [Abstract]
Common stock awards reserved for future issuance under 2020 and 2016 Equity Incentive Plans (in shares)
Common Stock, Capital Shares Reserved for Future Issuance, Effect Of Stock Awards Available For Future Grant
Common Stock, Capital Shares Reserved for Future Issuance, Effect Of Stock Awards Available For Future Grant
Milestone Determined by the Company
Milestone Determined by the Company [Member]
Milestone Determined by the Company
Number of leases
Lessee, Operating Lease, Number Of Lease Contracts
Lessee, Operating Lease, Number Of Lease Contracts
Other Comprehensive Income (Loss), Net of Tax [Abstract]
Other Comprehensive Income (Loss), Net of Tax [Abstract]
Event-Based Development Milestone
Event-Based Development Milestone [Member]
Event-Based Development Milestone
Forgone Recovery due to Disqualification of Tax Benefits, Amount
Forgone Recovery due to Disqualification of Tax Benefits, Amount
Prime Rate
Prime Rate [Member]
Product and Service [Domain]
Product and Service [Domain]
Stock options
Stock options, unexercised — vested and unvested
Share-Based Payment Arrangement, Option [Member]
Debt Securities, Available-for-Sale [Table]
Debt Securities, Available-for-Sale [Table]
Vested (usd per share)
Share-Based Compensation Arrangement by Share-Based Payment Award, Equity Instruments Other than Options, Vested in Period, Weighted Average Grant Date Fair Value
Fair Value Disclosures [Abstract]
Depreciation
Depreciation
Marketable securities
Marketable Securities, Current
Additional cash payment
Revenue, Remaining Performance Obligation, Additional Cash Payment
Revenue, Remaining Performance Obligation, Additional Cash Payment
Schedule of Antidilutive Securities Excluded from Computation of Earnings Per Share [Table]
Antidilutive Security, Excluded EPS Calculation [Table]
Comprehensive loss
Comprehensive Income (Loss), Net of Tax, Attributable to Parent
Preferred stock, outstanding (in shares)
Preferred Stock, Shares Outstanding
Number of remaining additional tranches
Debt Instrument, Number Of Remaining Additional Tranches
Debt Instrument, Number Of Remaining Additional Tranches
Other receivables
Increase (Decrease) in Other Receivables
Security Exchange Name
Security Exchange Name
Basis spread on variable rate (as a percent)
Debt Instrument, Basis Spread on Variable Rate
Award Type [Axis]
Award Type [Axis]
Corporate debt securities
Corporate Debt Securities [Member]
Earnings Per Share, Basic [Abstract]
Earnings Per Share, Basic [Abstract]
Exercised (usd per share)
Share-Based Compensation Arrangements by Share-Based Payment Award, Options, Exercises in Period, Weighted Average Exercise Price
Restricted Cash
Cash and Cash Equivalents, Restricted Cash and Cash Equivalents, Policy [Policy Text Block]
End of term charge, interest rate (as a percent)
Line of Credit Facility, Periodic Payment, Interest Rate
Line of Credit Facility, Periodic Payment, Interest Rate
Number of Shares
Share-Based Compensation Arrangement by Share-Based Payment Award, Equity Instruments Other than Options, Nonvested, Number of Shares [Roll Forward]
Work in progress
Inventory, Work in Process, Net of Reserves
Property and equipment, net
Property and equipment, net
Property, Plant and Equipment, Net
2023 ATM Prospectus
2023 ATM Prospectus [Member]
2023 ATM Prospectus
Total liabilities
Liabilities
Special cash dividend (usd per share)
Common Stock, Dividends, Per Share, Cash Paid
Exercisable (usd per share)
Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Exercisable, Weighted Average Exercise Price
Common stock, par value (usd per share)
Common Stock, Par or Stated Value Per Share
Forgone Recovery, Explanation of Impracticability
Forgone Recovery, Explanation of Impracticability [Text Block]
Research and development
Research and Development Expense
Schedule of Share-based Compensation Arrangements by Share-based Payment Award [Table]
Schedule of Share-Based Compensation Arrangements by Share-Based Payment Award [Table]
Schedule of Estimated Value of Cash, Cash Equivalents, Marketable Securities, and Equity Securities
Unrealized Gain (Loss) on Investments [Table Text Block]
Expiration Date
Trading Arrangement Expiration Date
Follow-On Public Offering
Follow-On Public Offering [Member]
Follow-On Public Offering
Cash Flows From Investing Activities:
Net Cash Provided by (Used in) Investing Activities [Abstract]
Operating lease liability, current
Operating Lease, Liability, Current
Total Shareholder Return Amount
Total Shareholder Return Amount
Common stock, issued (in shares)
Common Stock, Shares, Issued
Unvested
Share-Based Compensation Arrangement By Share-based Payment Award, Options, Nonvested, Aggregate Intrinsic Value
Share-Based Compensation Arrangement By Share-based Payment Award, Options, Nonvested, Aggregate Intrinsic Value
Entity [Domain]
Entity [Domain]
Equity Awards Adjustments, Footnote
Equity Awards Adjustments, Footnote [Text Block]
Credit facility, aggregate principal amount
Line of Credit Facility, Maximum Borrowing Capacity
Concentration risk
Concentration Risk, Percentage
Upfront payment received
Collaborative Arrangement, Rights And Obligations, Upfront Payment
Collaborative Arrangement, Rights And Obligations, Upfront Payment
Insider Trading Policies and Procedures Adopted
Insider Trading Policies and Procedures Adopted [Flag]
(Less): Accumulated depreciation
Accumulated Depreciation, Depletion and Amortization, Property, Plant, and Equipment
Pre-funded warrants reserved for future issuance (in shares)
Class of Warrant Or Right, Reserved for Future Issuance
Class of Warrant Or Right, Reserved for Future Issuance
Property and equipment, at cost
Property, Plant and Equipment, Gross
Pharmakon Credit Facility
Pharmakon Credit Facility [Member]
Pharmakon Credit Facility
Exercise of vested stock options (in shares)
Exercised (in shares)
Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Exercises in Period
Debt Instrument [Line Items]
Debt Instrument [Line Items]
Named Executive Officers, Footnote
Named Executive Officers, Footnote [Text Block]
Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding, Weighted Average Exercise Price [Abstract]
Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Outstanding, Weighted Average Exercise Price [Abstract]
Research and development
Research and Development Expense [Member]
Common stock, authorized (in shares)
Common Stock, Shares Authorized
Basis of Presentation
Basis of Accounting, Policy [Policy Text Block]
Weighted-average shares outstanding - diluted (in shares)
Weighted Average Number of Shares Outstanding, Diluted
Unrealized gain (loss) on marketable securities and cash equivalents
OCI, Debt Securities, Available-for-Sale, Gain (Loss), after Adjustment and Tax
MNPI Disclosure Timed for Compensation Value
MNPI Disclosure Timed for Compensation Value [Flag]
2025 (remaining nine months)
Finite-Lived Intangible Asset, Expected Amortization, Remainder of Fiscal Year
Long-term Debt, Type [Axis]
Long-Term Debt, Type [Axis]
Future cash payments
Collaborative Arrangement, Future Cash Payments
Collaborative Arrangement, Future Cash Payments
Total stockholders’ equity
Beginning balance
Ending balance
Equity, Attributable to Parent
Cash and Cash Equivalents
Cash and Cash Equivalents, Unrestricted Cash and Cash Equivalents, Policy [Policy Text Block]
OUT-LICENSE AGREEMENTS
Collaborative Arrangement Disclosure [Text Block]
Interest expense
Interest Expense, Nonoperating
Concentration Risk Type [Domain]
Concentration Risk Type [Domain]
Selling, general and administrative
Selling, General and Administrative Expense
Accounts receivable, net
Accounts Receivable, after Allowance for Credit Loss, Current
Granted (in shares)
Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Grants in Period, Gross
Cost of sales
Cost of Sales [Member]
Product sales, net
Product [Member]
Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items]
Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items]
Sale of Stock [Domain]
Sale of Stock [Domain]
Long-term debt, net
Long-Term Debt
Pension Adjustments Prior Service Cost
Pension Adjustments Prior Service Cost [Member]
Document Fiscal Period Focus
Document Fiscal Period Focus
All Executive Categories
All Executive Categories [Member]
Commercial Sales Milestone Payments
Commercial Sales Milestone Payments [Member]
Commercial Sales Milestone Payments
Unvested
Share-Based Compensation Arrangement By Share-Based Payment Award, Options, Nonvested, Weighted Average Remaining Contractual Term
Share-Based Compensation Arrangement By Share-Based Payment Award, Options, Nonvested, Weighted Average Remaining Contractual Term
2027
Finite-Lived Intangible Asset, Expected Amortization, Year Two
Changed Peer Group, Footnote
Changed Peer Group, Footnote [Text Block]
Outstanding
Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Outstanding, Weighted Average Remaining Contractual Term
ASSETS
Assets:
Assets [Abstract]
Fair Value, by Balance Sheet Grouping [Table]
Fair Value, by Balance Sheet Grouping [Table]
Other comprehensive loss
Other Comprehensive Income (Loss), Net of Tax
Dividend yield rate
Share-Based Compensation Arrangement by Share-Based Payment Award, Fair Value Assumptions, Expected Dividend Rate
Document Type
Document Type
Effective interest rate (as a percent)
Debt Instrument, Interest Rate, Effective Percentage
Commercial paper
Commercial Paper [Member]
Pension Benefits Adjustments, Footnote
Pension Benefits Adjustments, Footnote [Text Block]
Total Shareholder Return Vs Peer Group
Total Shareholder Return Vs Peer Group [Text Block]
Net proceeds
Proceeds from (Repayments of) Debt
Issuance of common stock upon the vesting of restricted stock units (in shares)
Stock Issued During Period, Shares, Restricted Stock Award, Gross
Interest expense for long-term debt
Interest Expense, Debt, Excluding Amortization
Exercisable
Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Exercisable, Weighted Average Remaining Contractual Term
Tranches with minimum net sales milestones
Debt Instrument, Number Of Tranches With Milestone Requirements
Debt Instrument, Number Of Tranches With Milestone Requirements
Vested (in shares)
Share-Based Compensation Arrangement by Share-Based Payment Award, Equity Instruments Other than Options, Vested in Period
Amortized cost
Amortized cost
Debt Securities, Available-for-Sale, Amortized Cost
Schedule of Expected Future Amortization Expense
Schedule of Finite-Lived Intangible Assets, Future Amortization Expense [Table Text Block]
Weighted average risk-free interest rate
Share-Based Compensation Arrangement by Share-Based Payment Award, Fair Value Assumptions, Risk Free Interest Rate
Maximum
Maximum [Member]
Marketable securities:
Debt Securities, Available-for-Sale [Abstract]
Amortization of intangible assets
Amortization of Intangible Assets
Upfront payment
Contract with Customer, Liability
Equity Valuation Assumption Difference, Footnote
Equity Valuation Assumption Difference, Footnote [Text Block]
Total future amortization
Finite-Lived Intangible Assets, Net
Furniture and fixtures
Furniture and Fixtures [Member]
Royalty expense
Royalty Expense
Antidilutive Securities [Axis]
Antidilutive Securities [Axis]
Accounting Policies [Abstract]
Revenues:
Revenues [Abstract]
Leasehold improvements
Leasehold Improvements [Member]
Upon Execution of the Novation Agreement
Upon Execution of the Novation Agreement [Member]
Upon Execution of the Novation Agreement
Schedule of Valuation Assumptions of Stock Options
Schedule of Share-Based Payment Award, Stock Options, Valuation Assumptions [Table Text Block]
Fair Value Measurements
Fair Value Measurement, Policy [Policy Text Block]
Current Fiscal Year End Date
Current Fiscal Year End Date
(Less): Imputed interest
Lessee, Operating Lease, Liability, Undiscounted Excess Amount
Five Customers
Five Customers [Member]
Five Customers
Upon Execution of Warrant Termination Agreement
Upon Execution of Warrant Termination Agreement [Member]
Upon Execution of Warrant Termination Agreement
Total lease expense
Lease, Cost
Accounts payable and other accrued liabilities
Accounts payable and other accrued liabilities
Accounts Payable and Other Accrued Liabilities, Current
Statistical Measurement [Axis]
Statistical Measurement [Axis]
PEO Name
PEO Name
License agreement
Collaborative Arrangement, Transaction with Party to Collaborative Arrangement [Member]
Non-Rule 10b5-1 Arrangement Terminated
Non-Rule 10b5-1 Arrangement Terminated [Flag]
LianBio
LianBio [Member]
LianBio
Non-PEO NEO Average Total Compensation Amount
Non-PEO NEO Average Total Compensation Amount
Award Type [Domain]
Award Type [Domain]
Name
Outstanding Recovery, Individual Name
Offering costs included within accounts payable and other accrued liabilities
Deferred Offering Costs Incurred But Not Yet Paid, Included In Accounts Payable And Accrued Liabilities
Deferred Offering Costs Incurred But Not Yet Paid, Included In Accounts Payable And Accrued Liabilities
Variable lease expense
Variable Lease, Cost
Schedule of Outstanding Potentially Dilutive Securities
Schedule of Antidilutive Securities Excluded from Computation of Earnings Per Share [Table Text Block]
Restricted stock units issued and outstanding (unvested) under 2020 Equity Incentive Plan (in shares)
Common Stock, Capital Shares Reserved for Future Issuance, Effect Of Restricted Stock Units Available For Future Grant
Common Stock, Capital Shares Reserved for Future Issuance, Effect Of Restricted Stock Units Available For Future Grant
Compensation Actually Paid vs. Company Selected Measure
Compensation Actually Paid vs. Company Selected Measure [Text Block]
Non-PEO NEO
Non-PEO NEO [Member]
Useful life (in years)
Finite-Lived Intangible Asset, Useful Life
Additional Paid-In Capital
Additional Paid-in Capital [Member]
Award Timing Predetermined
Award Timing Predetermined [Flag]
Restricted cash, non-current
Restricted Cash, Noncurrent
Recently Issued or Effective Accounting Standards
New Accounting Pronouncements, Policy [Policy Text Block]
Forecast
Forecast [Member]
Net loss per share - diluted (usd per share)
Earnings Per Share, Diluted
Counterparty Name [Domain]
Counterparty Name [Domain]
(Less): Accumulated amortization
Finite-Lived Intangible Assets, Accumulated Amortization
Schedule of Finite-Lived Intangible Assets
Finite-Lived Intangible Assets Amortization Expense [Table Text Block]
Name
Measure Name
Entity Interactive Data Current
Entity Interactive Data Current
Restatement does not require Recovery
Restatement Does Not Require Recovery [Text Block]
Number of securities with contractual maturity between one and three years
Debt Securities, Available-for-Sale, Contractual Maturities Greater Than Twelve Months, Number of Securities
Debt Securities, Available-for-Sale, Contractual Maturities Greater Than Twelve Months, Number of Securities
Preferred stock, issued (in shares)
Preferred Stock, Shares Issued
Customer [Axis]
Customer [Axis]
Accounts payable and other accrued liabilities
Increase (Decrease) in Other Accounts Payable and Accrued Liabilities
Statement of Financial Position [Abstract]
Unvested (usd per share)
Share-Based Compensation Arrangement by Share-Based Payment Award, Option, Nonvested, Weighted Average Exercise Price
Interest rate floor (as a percent)
Debt Instrument, Floor Interest Rate
Debt Instrument, Floor Interest Rate
Stock-based compensation
Share-Based Payment Arrangement, Noncash Expense
Selling and marketing
Selling and Marketing Expense
End of term charge
Line of Credit Facility, Periodic Payment, Interest
Other income (expense):
Nonoperating Income (Expense) [Abstract]
Issuance of pre-funded warrants, net of issuance costs
Adjustments to Additional Paid in Capital, Warrant Issued
Unrecognized compensation expense, weighted average period of recognition (in years)
Share-Based Payment Arrangement, Nonvested Award, Cost Not yet Recognized, Period for Recognition
Revenue recognized
Revenue from Contract with Customer, Excluding Assessed Tax
Total other income (expense), net
Nonoperating Income (Expense)
Other long-term liabilities
Increase (Decrease) in Other Noncurrent Liabilities
Grandpharma
Grandpharma [Member]
Grandpharma
Concentration Risk Benchmark [Domain]
Concentration Risk Benchmark [Domain]
Bobak Azamian [Member]
Bobak Azamian
Net cash used in investing activities
Net Cash Provided by (Used in) Investing Activities
Loss from operations before other income (expense)
Operating Income (Loss)
Variable Rate [Domain]
Variable Rate [Domain]
Number of reportable segments
Number of Reportable Segments
Total liabilities and stockholders’ equity
Liabilities and Equity
Rule 10b5-1 Arrangement Terminated
Rule 10b5-1 Arrangement Terminated [Flag]
All Adjustments to Compensation
All Adjustments to Compensation [Member]
Fair Value Hierarchy and NAV [Axis]
Fair Value Hierarchy and NAV [Axis]
Accrued payroll and benefits
Employee-related Liabilities, Current
Marketable Securities and Long-Term Investments
Marketable Securities, Policy [Policy Text Block]
Additional paid-in capital
Additional Paid in Capital
Collaborative Arrangement and Arrangement Other than Collaborative [Table]
Collaborative Arrangement and Arrangement Other than Collaborative [Table]
Commitments and Contingencies Disclosure [Abstract]
Commitments and Contingencies Disclosure [Abstract]
Aziz Mottiwala [Member]
Aziz Mottiwala
Legal Entity [Axis]
Legal Entity [Axis]
Schedule of Restricted Stock Unit Activity
Share-Based Payment Arrangement, Restricted Stock and Restricted Stock Unit, Activity [Table Text Block]
Long-Lived Asset, Held-for-Sale [Table]
Long-Lived Asset, Held-for-Sale [Table]
Operating lease right-of-use asset obtained in exchange for operating lease liability
Right-of-Use Asset Obtained in Exchange for Operating Lease Liability
Development and Regulatory Milestone
Development And Regulatory Milestone [Member]
Development And Regulatory Milestone
Underlying Security Market Price Change
Underlying Security Market Price Change, Percent
Scenario [Domain]
Scenario [Domain]
Individual:
Individual [Axis]
Accumulated Other Comprehensive Gain (Loss)
AOCI Attributable to Parent [Member]
Forfeited (usd per share)
Share-Based Compensation Arrangements by Share-Based Payment Award, Options, Forfeitures in Period, Weighted Average Exercise Price
Expected term (in years)
Share-Based Compensation Arrangement by Share-Based Payment Award, Fair Value Assumptions, Expected Term
Inventory
Inventory
Inventory, Net
Long-term Debt, Type [Domain]
Long-Term Debt, Type [Domain]
Commercial and sales milestones
Commercial And Sales Milestones [Member]
Commercial And Sales Milestones
Product and Service [Axis]
Product and Service [Axis]
Entity Address, State or Province
Entity Address, State or Province
Property, Plant and Equipment [Line Items]
Property, Plant and Equipment [Line Items]
Statement [Line Items]
Statement [Line Items]
Erroneous Compensation Analysis
Erroneous Compensation Analysis [Text Block]
Trade accounts payable and other
Accounts Payable, Trade, Current
Schedule of Operating Financial Results of Therapeutics Segment
Reconciliation of Operating Profit (Loss) from Segments to Consolidated [Table Text Block]
Operating expenses:
Operating Expenses [Abstract]
Schedule of Property and Equipment, Net of Accumulated Depreciation
Property, Plant and Equipment [Table Text Block]
Compensation Actually Paid vs. Total Shareholder Return
Compensation Actually Paid vs. Total Shareholder Return [Text Block]
Financial Instruments [Domain]
Financial Instruments [Domain]
Outstanding, beginning balance (usd per share)
Outstanding, ending balance (usd per share)
Share-Based Compensation Arrangement by Share-Based Payment Award, Equity Instruments Other than Options, Nonvested, Weighted Average Grant Date Fair Value
LIABILITIES AND STOCKHOLDERS' EQUITY
Liabilities and Equity [Abstract]
Issuance costs, warrants
Class of Warrant or Right, Payments of Issuance Costs
Class of Warrant or Right, Payments of Issuance Costs
Intangible Assets, Milestone Payment
Intangible Assets, Milestone Payment [Member]
Intangible Assets, Milestone Payment
Weighted-Average Remaining Contractual Term
Share-based Compensation Arrangement by Share-Based Payment Award, Options, Outstanding, Weighted Average Remaining Contractual Term [Abstract]
Share-based Compensation Arrangement by Share-Based Payment Award, Options, Outstanding, Weighted Average Remaining Contractual Term
Minimum
Minimum [Member]
Restatement Determination Date
Restatement Determination Date
Share-Based Compensation Arrangement By Share-Based Payment Award, Options, Aggregate Intrinsic Value [Abstract]
Share-Based Compensation Arrangement By Share-Based Payment Award, Options, Aggregate Intrinsic Value [Abstract]
Share-Based Compensation Arrangement By Share-Based Payment Award, Options, Aggregate Intrinsic Value
Contractual maturity
Debt Securities, Available-for-Sale, Term
Adoption Date
Trading Arrangement Adoption Date
Pay vs Performance Disclosure
Pay vs Performance Disclosure [Table]
Related Party Transactions [Abstract]
Common stock votes
Common Stock, Number Of Votes
Common Stock, Number Of Votes
Property, Plant and Equipment [Table]
Property, Plant and Equipment [Table]
Beginning balance (usd per share)
Ending balance (usd per share)
Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Outstanding, Weighted Average Exercise Price
Operating lease right-of-use assets
Operating Lease, Right-of-Use Asset
Erroneously Awarded Compensation Recovery
Erroneously Awarded Compensation Recovery [Table]
Beginning balance (in shares)
Ending balance (in shares)
Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Outstanding, Number
Segments [Axis]
Segments [Axis]
Stock options issued and outstanding (unvested and vested) under 2020 and 2016 Equity Incentive Plans (in shares)
Common Stock, Capital Shares Reserved for Future Issuance, Effect Of Stock Options Issued And Outstanding
Common Stock, Capital Shares Reserved for Future Issuance, Effect Of Stock Options Issued And Outstanding
Change in Fair Value as of Vesting Date of Prior Year Equity Awards Vested in Covered Year
Change in Fair Value as of Vesting Date of Prior Year Equity Awards Vested in Covered Year [Member]
Principal outstanding
Long-term debt, gross
Long-Term Debt, Gross
Exercise Price
Award Exercise Price
NET LOSS PER SHARE
Earnings Per Share [Text Block]
Accrued payroll and benefits
Increase (Decrease) in Employee Related Liabilities
Arrangement Duration
Trading Arrangement Duration
Accrued royalty payable
Accrued Royalty Payable, Current
Accrued Royalty Payable, Current
Exercise of vested stock options
Stock Issued During Period, Value, Stock Options Exercised
Stockholders’ equity:
Equity, Attributable to Parent [Abstract]
Granted (usd per share)
Share-Based Compensation Arrangement by Share-Based Payment Award, Equity Instruments Other than Options, Grants in Period, Weighted Average Grant Date Fair Value
Two Customers
Two Customers [Member]
Two Customers
Long-term investments
Long-Term Investments
Income Taxes
Income Tax, Policy [Policy Text Block]
Peer Group Issuers, Footnote
Peer Group Issuers, Footnote [Text Block]
Segments [Domain]
Segments [Domain]
Material Terms of Trading Arrangement
Material Terms of Trading Arrangement [Text Block]
2029
Finite-Lived Intangible Asset, Expected Amortization, Year Four
All Individuals
All Individuals [Member]
Draw on credit facility
Proceeds from Lines of Credit
Price per warrant (usd per share)
Class of Warrant or Right, Sale Price
Class of Warrant or Right, Sale Price
PEO
PEO [Member]
Variable Rate [Axis]
Variable Rate [Axis]
Name
Trading Arrangement, Individual Name
Other income (expense), net
Other Nonoperating Income (Expense)
Statement of Stockholders' Equity [Abstract]
Intangible assets, net
Intangible assets, net
Intangible Assets, Net (Excluding Goodwill)
Security deposit
Security Deposit Liability
Long-Lived Tangible Asset [Axis]
Long-Lived Tangible Asset [Axis]
Unrealized gains
Debt Securities, Available-for-Sale, Accumulated Gross Unrealized Gain, before Tax
Other non-current assets
Increase (Decrease) in Other Noncurrent Assets
Remaining lease term (years)
Lessee, Operating Lease, Remaining Lease Term
Unrecognized compensation expense
Share-Based Payment Arrangement, Nonvested Award, Excluding Option, Cost Not yet Recognized, Amount
Thereafter
Finite-Lived Intangible Asset, Expected Amortization, after Year Four
Finite-Lived Intangible Asset, Expected Amortization, after Year Four
Awards Close in Time to MNPI Disclosures, Table
Awards Close in Time to MNPI Disclosures [Table Text Block]
Share-based Payment Arrangement, Expensed and Capitalized, Amount [Table]
Share-Based Payment Arrangement, Expensed and Capitalized, Amount [Table]
Total shares of common stock reserved (in shares)
Common Stock, Capital Shares Reserved for Future Issuance
Prior Year End Fair Value of Equity Awards Granted in Any Prior Year that Fail to Meet Applicable Vesting Conditions During Covered Year
Prior Year End Fair Value of Equity Awards Granted in Any Prior Year that Fail to Meet Applicable Vesting Conditions During Covered Year [Member]
Accrued product sales deductions
Accrued Sales Commission, Current
Cash and cash equivalents
Cash and Cash Equivalents, Fair Value Disclosure
Aggregate Erroneous Compensation Amount
Aggregate Erroneous Compensation Amount
Local Phone Number
Local Phone Number
Intangible assets, gross
Intangible Assets, Gross (Excluding Goodwill)
Aggregate Erroneous Compensation Not Yet Determined
Aggregate Erroneous Compensation Not Yet Determined [Text Block]
Debt issuance costs
Debt Issuance Costs, Line of Credit Arrangements, Net
Sales-based Milestones
Sales-Based Milestones [Member]
Sales-based Milestones
Service condition period for full vesting (in years)
Share-Based Compensation Arrangement by Share-Based Payment Award, Award Requisite Service Period
Changes in operating assets and liabilities:
Increase (Decrease) in Operating Capital [Abstract]
Secured Overnight Financing Rate (SOFR)
Secured Overnight Financing Rate (SOFR) [Member]
PEO Total Compensation Amount
PEO Total Compensation Amount
Fair market value of common stock (as a percent)
Share-Based Compensation Arrangement by Share-Based Payment Award, Purchase Price of Common Stock, Percent
Amortized cost
Equity Securities, FV-NI, Cost
Long-Lived Tangible Asset [Domain]
Long-Lived Tangible Asset [Domain]
Income Statement Location [Axis]
Statement of Income Location, Balance [Axis]
Pharmakon Credit Facility, Tranche Two
Pharmakon Credit Facility, Tranche Two [Member]
Pharmakon Credit Facility, Tranche Two
Issuance costs
Payments of Stock Issuance Costs
COMMITMENTS & CONTINGENCIES
Commitments and Contingencies Disclosure [Text Block]
Debt Disclosure [Abstract]
Common Stock
Common Stock [Member]
Measure:
Measure [Axis]
(Less): Tenant improvement allowance
Lessee, Operating Lease, Liability, Tenant Improvement Allowance
Lessee, Operating Lease, Liability, Tenant Improvement Allowance
Long-Lived Assets Held-for-Sale by Asset Type [Axis]
Long-Lived Asset, Held-for-Sale, Type [Axis]
Preferred stock, authorized (in shares)
Preferred Stock, Shares Authorized
Forgone Recovery due to Expense of Enforcement, Amount
Forgone Recovery due to Expense of Enforcement, Amount
Issuance of common stock, net of issuance costs (in shares)
Stock Issued During Period, Shares, New Issues
Line of Credit
Line of Credit [Member]
Entity Emerging Growth Company
Entity Emerging Growth Company
Reportable Segment
Reportable Segment [Member]
Reportable Segment
Segment Reporting [Abstract]
Intangible Assets, Net
Goodwill and Intangible Assets, Intangible Assets, Policy [Policy Text Block]
Entity Central Index Key
Entity Central Index Key
Scenario [Axis]
Scenario [Axis]
Other reconciling items
Segment Reporting, Other Segment Item, Amount
Restricted stock units — unvested
Share-Based Payment Arrangement, Equity Instruments Other Than Options, Restricted Stock Units, Unvested [Member]
Share-Based Payment Arrangement, Equity Instruments Other Than Options, Restricted Stock Units, Unvested
Schedule of Inventories
Schedule of Inventory, Current [Table Text Block]
Lessee, Lease, Description [Table]
Lessee, Lease, Description [Table]
Non-GAAP Measure Description
Non-GAAP Measure Description [Text Block]
Non-PEO NEO Average Compensation Actually Paid Amount
Non-PEO NEO Average Compensation Actually Paid Amount
Schedule of Accounts Payable and Accrued Liabilities
Schedule of Accounts Payable and Accrued Liabilities [Table Text Block]
License fees and collaboration revenue
License And Collaboration [Member]
License And Collaboration
Award Timing, How MNPI Considered
Award Timing, How MNPI Considered [Text Block]
Equity Component [Domain]
Equity Component [Domain]
Preferred stock, par value (usd per share)
Preferred Stock, Par or Stated Value Per Share
Financial Instrument [Axis]
Financial Instrument [Axis]
SEGMENT REPORTING
Segment Reporting Disclosure [Text Block]
Additional 402(v) Disclosure
Additional 402(v) Disclosure [Text Block]
Recognition of stock-based compensation expense
APIC, Share-Based Payment Arrangement, Increase for Cost Recognition
Rent abatement
Incentive from Lessor
Entity Shell Company
Entity Shell Company
Entity Incorporation, State or Country Code
Entity Incorporation, State or Country Code
Available-for-sale Debt Securities, Contractual Maturity Less Than 12 Months
Available-for-sale Debt Securities, Contractual Maturity Greater Than 12 Months [Member]
Available-for-sale Debt Securities, Contractual Maturity Greater Than 12 Months
Comprehensive Loss
Comprehensive Income, Policy [Policy Text Block]
Clinical milestones
Clinical Milestones [Member]
Clinical Milestones
Title
Trading Arrangement, Individual Title
Statement [Table]
Statement [Table]
Total interest expense
Interest Expense, Debt
Counterparty Name [Axis]
Counterparty Name [Axis]
SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES AND USE OF ESTIMATES
Significant Accounting Policies [Text Block]
City Area Code
City Area Code
Current liabilities:
Liabilities, Current [Abstract]
Interest expense paid in cash
Interest Paid, Excluding Capitalized Interest, Operating Activities
Revenue Recognition
Revenue [Policy Text Block]
Insider Trading Policies and Procedures Not Adopted
Insider Trading Policies and Procedures Not Adopted [Text Block]
Level 1
Fair Value, Inputs, Level 1 [Member]
Concentration Risk Benchmark [Axis]
Concentration Risk Benchmark [Axis]
Total current assets
Assets, Current
Schedule of Interest Expense
Interest Income and Interest Expense Disclosure [Table Text Block]
Statement of Cash Flows [Abstract]
Supplemental Disclosures From Noncash, Investing and Financing Activities:
Noncash Investing and Financing Items [Abstract]
Exercisable (in shares)
Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Exercisable, Number
Schedule of Long-term Debt Instruments [Table]
Schedule of Long-Term Debt Instruments [Table]
Long-term debt, net
Long-Term Debt, Excluding Current Maturities
Schedule of Segment Reporting Information, by Segment [Table]
Schedule of Segment Reporting Information, by Segment [Table]
Weighted Average Value per Share
Share-Based Compensation Arrangement by Share-Based Payment Award, Equity Instruments Other than Options, Nonvested, Weighted Average Grant Date Fair Value [Abstract]
Weighted-average grant-date fair value per stock option (usd per share)
Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Grants in Period, Weighted Average Grant Date Fair Value
Accumulated amortization of debt issuance costs
Accumulated Amortization, Debt Issuance Costs
Earnings Per Share [Abstract]
Earnings Per Share [Abstract]
Accumulated deficit
Retained Earnings (Accumulated Deficit)
Inventory
Increase (Decrease) in Inventories
Schedule of Balances of Debt, Debt Issuance Costs, and Accumulated Accretion
Schedule of Debt [Table Text Block]
Common stock awards reserved for future issuance under the 2020 Employee Stock Purchase Plan (in shares)
Common Stock, Capital Shares Reserved for Future Issuance, Employee Stock Purchase Plan
Common Stock, Capital Shares Reserved for Future Issuance, Employee Stock Purchase Plan
Organization, Consolidation and Presentation of Financial Statements [Abstract]
Aggregate Available
Trading Arrangement, Securities Aggregate Available Amount
Change in fair value of equity warrants issued by licensee
Embedded Derivative, Gain (Loss) on Embedded Derivative, Net
Equity Awards Adjustments
Equity Awards Adjustments [Member]
Discount rate
Operating Lease, Weighted Average Discount Rate, Percent
Total operating lease liability
Total operating lease liability
Operating Lease, Liability
Net cash provided by financing activities
Net Cash Provided by (Used in) Financing Activities
Underlying Securities
Award Underlying Securities Amount
Performance Shares
Performance Shares [Member]
Elanco
Elanco [Member]
Elanco
Special cash dividends paid
Dividends, Common Stock, Cash
Interest income
Interest Income, Other
Amendment Flag
Amendment Flag
Entity Registrant Name
Entity Registrant Name
Potential additional tranches
Debt Instrument, Number Of Potential Additional Tranches
Debt Instrument, Number Of Potential Additional Tranches
Adjustment to Non-PEO NEO Compensation Footnote
Adjustment to Non-PEO NEO Compensation Footnote [Text Block]
Stock Appreciation Rights (SARs)
Stock Appreciation Rights (SARs) [Member]
Depreciation and amortization expense
Depreciation, Depletion and Amortization
Number of available-for-sale debt securities in gross unrealized loss position for less than one year
Debt Securities, Available-for-Sale, Continuous Unrealized Loss Position, Less than 12 Months, Number of Positions
Manufacturing equipment
Machinery and Equipment [Member]
Fair Value as of Grant Date
Award Grant Date Fair Value
Customer Concentration Risk
Customer Concentration Risk [Member]
Authorized consideration
Sale of Stock, Consideration Amount Authorized
Sale of Stock, Consideration Amount Authorized
Credit Facility, Tranche One
Credit Facility, Tranche One [Member]
Credit Facility, Tranche One
Selling, General and Administrative
Selling, General and Administrative Expenses, Policy [Policy Text Block]
Level 2
Fair Value, Inputs, Level 2 [Member]
Stock issued (in shares)
Sale of Stock, Number of Shares Issued in Transaction
CREDIT FACILITY AGREEMENTS
Debt Disclosure [Text Block]
Remaining useful life
Finite-Lived Intangible Assets, Remaining Amortization Period
Fair Value Hierarchy and NAV [Domain]
Fair Value Hierarchy and NAV [Domain]
Unvested (in shares)
Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Nonvested, Number of Shares
Recovery of Erroneously Awarded Compensation Disclosure [Line Items]
Issuance of common stock, net of issuance costs
Stock Issued During Period, Value, New Issues
Entity Address, Postal Zip Code
Entity Address, Postal Zip Code
Collaborative Arrangement and Arrangement Other than Collaborative [Axis]
Collaborative Arrangement and Arrangement Other than Collaborative [Axis]
Schedule of Stock Based Compensation
Share-Based Payment Arrangement, Expensed and Capitalized, Amount [Table Text Block]
Restatement Determination Date:
Restatement Determination Date [Axis]
Collaborative Arrangement and Arrangement Other than Collaborative [Domain]
Collaborative Arrangement and Arrangement Other than Collaborative [Domain]
Title of 12(b) Security
Title of 12(b) Security
Upfront payment received
Upfront Payment
Upfront Payment
Concentration Risk Type [Axis]
Concentration Risk Type [Axis]
Common stock, $0.0001 par value; 200,000,000 shares authorized; 41,995,537 shares issued and outstanding at March 31, 2025 (unaudited); 38,349,826 shares issued and outstanding at December 31, 2024
Common Stock, Value, Issued
Share-Based Payment Arrangement [Abstract]
Government-related debt securities
US Government Debt Securities [Member]
Amortized cost
Cash and Cash Equivalents, at Carrying Value
Milestone payments to be achieved
Revenue, Remaining Performance Obligation, Variable Consideration, Amount
Revenue, Remaining Performance Obligation, Variable Consideration, Amount
Year-over-Year Change in Fair Value of Equity Awards Granted in Prior Years That are Outstanding and Unvested
Year-over-Year Change in Fair Value of Equity Awards Granted in Prior Years That are Outstanding and Unvested [Member]
Forfeited (usd per share)
Share-Based Compensation Arrangement by Share-Based Payment Award, Equity Instruments Other than Options, Forfeitures, Weighted Average Grant Date Fair Value
Loss on debt extinguishment
Gain (Loss) on Extinguishment of Debt
Impairments of intangible assets
Impairment of Intangible Assets (Excluding Goodwill)
Annual increase in rent
Lessee, Operating Lease, Annual Rent Increase, Percent
Lessee, Operating Lease, Annual Rent Increase, Percent
Cash Flows From Financing Activities:
Net Cash Provided by (Used in) Financing Activities [Abstract]
Year-end Fair Value of Equity Awards Granted in Covered Year that are Outstanding and Unvested
Year-end Fair Value of Equity Awards Granted in Covered Year that are Outstanding and Unvested [Member]
Preferred stock, $0.0001 par value; 10,000,000 authorized; no shares issued and outstanding
Preferred Stock, Value, Issued
Useful lives of assets (in years)
Property, Plant and Equipment, Useful Life
Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding [Roll Forward]
Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Outstanding [Roll Forward]
Employee stock
Employee Stock [Member]
Net loss per share - basic (usd per share)
Earnings Per Share, Basic
2023 Shelf Registration Statement
2023 Shelf Registration Statement [Member]
2023 Shelf Registration Statement
Proceeds from issuance of common stock, net of paid issuance costs
Proceeds from Issuance of Common Stock
Cash paid for operating leases
Operating Lease, Payments
Adjustment To PEO Compensation, Footnote
Adjustment To PEO Compensation, Footnote [Text Block]
Award Timing MNPI Disclosure
Award Timing MNPI Disclosure [Text Block]
Additions of property and equipment included within accounts payable and other accrued liabilities
Capital Expenditures Incurred but Not yet Paid
Aggregate Pension Adjustments Service Cost
Aggregate Pension Adjustments Service Cost [Member]
Property and Equipment, Net
Property, Plant and Equipment, Policy [Policy Text Block]
Compensation Actually Paid vs. Other Measure
Compensation Actually Paid vs. Other Measure [Text Block]
Total current liabilities
Liabilities, Current
Vesting Date Fair Value of Equity Awards Granted and Vested in Covered Year
Vesting Date Fair Value of Equity Awards Granted and Vested in Covered Year [Member]
Weighted Average Number of Shares Outstanding, Diluted [Abstract]
Weighted Average Number of Shares Outstanding, Diluted [Abstract]
Unrecognized compensation expense
Share-Based Payment Arrangement, Nonvested Award, Option, Cost Not yet Recognized, Amount
Total assets
Assets
Concentration Risk
Concentration Risk, Credit Risk, Policy [Policy Text Block]
Weighted average volatility
Share-Based Compensation Arrangement by Share-Based Payment Award, Fair Value Assumptions, Weighted Average Volatility Rate
2026
Finite-Lived Intangible Asset, Expected Amortization, Year One
Cost of sales
Cost of Goods and Services Sold
Pharmakon Credit Facility, Tranche Three
Pharmakon Credit Facility, Tranche Three [Member]
Pharmakon Credit Facility, Tranche Three
Granted (in shares)
Share-Based Compensation Arrangement by Share-Based Payment Award, Equity Instruments Other than Options, Grants in Period
Long-Lived Assets Held-for-Sale, Name [Domain]
Long-Lived Assets Held-for-Sale, Name [Domain]
Cash equivalents:
Cash and Cash Equivalents [Abstract]
Underwriters' option
Over-Allotment Option [Member]
Purchases of property and equipment
Payments to Acquire Property, Plant, and Equipment
Forgone Recovery due to Violation of Home Country Law, Amount
Forgone Recovery due to Violation of Home Country Law, Amount
Commitments and contingencies (Note 8)
Commitments and Contingencies
Stock-Based Compensation
Share-Based Payment Arrangement [Policy Text Block]
Termination Date
Trading Arrangement Termination Date
DESCRIPTION OF BUSINESS AND PRESENTATION OF FINANCIAL STATEMENTS
Business Description and Basis of Presentation [Text Block]
Exercise price per warrant (usd per share)
Class of Warrant or Right, Exercise Price of Warrants or Rights
Total revenues
Revenues
STOCK-BASED COMPENSATION
Share-Based Payment Arrangement [Text Block]
Entity Address, City or Town
Entity Address, City or Town
Leases
Lessee, Leases [Policy Text Block]
Debt Instrument [Axis]
Debt Instrument [Axis]
Schedule of Stock Option Activity
Share-Based Payment Arrangement, Option, Activity [Table Text Block]
Total stock-based compensation
Share-Based Payment Arrangement, Expense
Net loss
Net loss
Net loss
Net Income (Loss) Attributable to Parent
Trading Arrangement:
Trading Arrangement [Axis]
Schedule of Financial Instruments Measured at Fair Value
Fair Value, by Balance Sheet Grouping [Table Text Block]
Accretion of end of term charge
Amortization of Debt Discount (Premium)
Granted (usd per share)
Share-Based Compensation Arrangements by Share-Based Payment Award, Options, Grants in Period, Weighted Average Exercise Price
Pay vs Performance Disclosure, Table
Pay vs Performance [Table Text Block]
Forfeited (in shares)
Share-Based Compensation Arrangement by Share-Based Payment Award, Equity Instruments Other than Options, Forfeited in Period
Square feet of office space
Area of Real Estate Property
Debt securities, available for sale and cash and cash equivalents
Debt Securities, Available-For-Sale And Cash And Cash Equivalents
Debt Securities, Available-For-Sale And Cash And Cash Equivalents
Equity Awards Adjustments, Excluding Value Reported in Compensation Table
Equity Awards Adjustments, Excluding Value Reported in the Compensation Table [Member]
Dividends or Other Earnings Paid on Equity Awards not Otherwise Reflected in Total Compensation for Covered Year
Dividends or Other Earnings Paid on Equity Awards not Otherwise Reflected in Total Compensation for Covered Year [Member]
Entity File Number
Entity File Number
Document Fiscal Year Focus
Document Fiscal Year Focus
Income Statement [Abstract]
Entity Address, Address Line One
Entity Address, Address Line One
Debt Instrument, Name [Domain]
Debt Instrument, Name [Domain]
Lease term
Lessee, Operating Lease, Term of Contract
Total assets measured at fair value
Assets, Fair Value Disclosure
Name
Forgone Recovery, Individual Name
2025 (remaining nine months)
Lessee, Operating Lease, Liability, to be Paid, Remainder of Fiscal Year
Exercisable
Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Exercisable, Intrinsic Value
Document Period End Date
Document Period End Date
Sale of Stock [Axis]
Sale of Stock [Axis]
Finished goods
Inventory, Finished Goods, Net of Reserves
Award Timing MNPI Considered
Award Timing MNPI Considered [Flag]
Number of employment arrangements with executive officers
Number Of Employment Arrangements With Executive Officers
Number Of Employment Arrangements With Executive Officers
Total future lease payments, undiscounted
Lessee, Operating Lease, Liability, to be Paid
Outstanding, beginning balance (in shares)
Outstanding, ending balance (in shares)
Share-Based Compensation Arrangement by Share-Based Payment Award, Equity Instruments Other than Options, Nonvested, Number
Insider Trading Arrangements [Line Items]
BALANCE SHEET ACCOUNT DETAIL
Supplemental Balance Sheet Disclosures [Text Block]
Schedule of Performance Stock Unit Activity
Share-Based Payment Arrangement, Performance Shares, Activity [Table Text Block]
Outstanding Aggregate Erroneous Compensation Amount
Outstanding Aggregate Erroneous Compensation Amount
Schedule of Stock Details
Schedule of Stock by Class [Table Text Block]
Fair Value, Balance Sheet Grouping, Financial Statement Captions [Line Items]
Fair Value, Balance Sheet Grouping, Financial Statement Captions [Line Items]
PEO Actually Paid Compensation Amount
PEO Actually Paid Compensation Amount
Total inventory
Inventory, Current And Noncurrent, Net
Inventory, Current And Noncurrent, Net
Adjustment to Compensation:
Adjustment to Compensation [Axis]
Accounts Receivable
Accounts Receivable [Member]
Document Transition Report
Document Transition Report
Document Quarterly Report
Document Quarterly Report
Customer [Domain]
Customer [Domain]
Accumulated other comprehensive income (loss)
Accumulated Other Comprehensive Income (Loss), Net of Tax
Entity Current Reporting Status
Entity Current Reporting Status
Accumulated Deficit
Retained Earnings [Member]
Non-current assets:
Inventory, Noncurrent [Abstract]
Amortization of debt issuance costs
Amortization of Debt Issuance Costs
Pension Adjustments Service Cost
Pension Adjustments Service Cost [Member]
Thereafter
Lessee, Operating Lease, Liability, to be Paid, After Current Fiscal Year
Lessee, Operating Lease, Liability, to be Paid, After Current Fiscal Year
Laboratory equipment
Other Machinery and Equipment [Member]
Pharmakon Credit Facility, Tranche Four
Pharmakon Credit Facility, Tranche Four [Member]
Pharmakon Credit Facility, Tranche Four
Weighted-average shares outstanding, basic (in shares)
Weighted-average shares outstanding - basic (in shares)
Weighted Average Number of Shares Outstanding, Basic
Stock Price or TSR Estimation Method
Stock Price or TSR Estimation Method [Text Block]
Inventory, non-current
Inventory, non-current
Inventory, Noncurrent
Restricted stock
Restricted Stock Units (RSUs) [Member]
Amortization of debt-related costs
Amortization of Debt Issuance Costs and Discounts
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Executive Category:
Executive Category [Axis]
Name
Awards Close in Time to MNPI Disclosures, Individual Name
Revenue Benchmark
Revenue Benchmark [Member]
Forfeited (in shares)
Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Forfeitures in Period
Entity Filer Category
Entity Filer Category
Income Statement Location [Domain]
Statement of Income Location, Balance [Domain]
Purchases of marketable securities
Payments to Acquire Debt Securities, Available-for-Sale
Company Selected Measure Name
Company Selected Measure Name